-
AI System Can Detect, Grade Cancer in Prostate Needle Biopsy
drugs
January 16, 2020
An artificial intelligence (AI) system can be used to detect and grade prostate cancer in prostate needle biopsy samples, according to a study published online January in The Lancet Oncology.
-
Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery
worldpharmanews
January 14, 2020
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration.
-
Funding for AI in drug development, clinical trials and information synthesis hits $5.2bn
europeanpharmaceuticalreview
January 09, 2020
A study has suggested that while funding for artificial intelligence in pharma was $5.2bn in 2019, overall investment is slowing.
-
Laser-Based Imaging + AI May Diagnose Brain Tumors in OR
drugs
January 07, 2020
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room, according to a study published online Jan. 6 in Nature Medicine.
-
AI Beat Humans in Spotting Breast Tumors
drugs
January 06, 2020
Machines can be trained to outperform humans when it comes to catching breast tumors on mammograms, a new study suggests.Researchers at Google and several universities are working on an artificial intelligence (AI) model aimed at ...
-
AI System Outperforms Radiologists in Breast Cancer Prediction
drugs
January 03, 2020
An artificial intelligence (AI) system can reduce false positives and false negatives in prediction of breast cancer and outperforms human readers, according to a study published online Jan. 1 in Nature.
-
Almirall signs deal for Iktos’ AI technology in drug design
pharmaceutical-technology
December 16, 2019
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
-
Research shows the pharma industry believes AI will likely optimise R&D
europeanpharmaceuticalreview
December 11, 2019
A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront of this.
-
Boehringer partners with Healx for AI-based drug discovery
pharmaceutical-technology
December 11, 2019
German pharmaceutical company Boehringer Ingelheim has partnered with UK-based drug technology firm Healx to identify approaches to treat rare neurological disorders.
-
Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions
En-CPhI.CN
October 11, 2019
Nearly 50% of patients with diabetes fail to get an annual eye examination done even in the US and EU.